Skip to menu Skip to content Skip to footer

2025

Journal Article

MGBase: a global, observational registry for collaborative research in myasthenia gravis

Buzzard, Katherine A., Van der Walt, Anneke, Butzkueven, Helmut, Zhang, Wen Wen, Barnett-Tapia, Carolina, Cutter, Gary, Heckmann, Jeannine M., Farr, Pamela, Tran, Carolyn, Sartori, Charlotte, Stupar, Dusko, More, Rein, Sim, Linda, Le, Alison, Tang, Qingxiao, Reddel, Stephen W., Blum, Stefan (MGBase Study Group member), Lovas, Gabvor, McCombe, Pamela (MGBase Study Group member), Chroni, Elisabeth, Cruse, Belinda, Alroughani, Raed, Tzartos, John, Gomex-Figueroa, Enrique, Boz, Cavit, Karelis, Guntis, Kermode, Allan and Crump, Nicholas (2025). MGBase: a global, observational registry for collaborative research in myasthenia gravis. Muscle and Nerve, 72 (3), 424-432. doi: 10.1002/mus.28450

MGBase: a global, observational registry for collaborative research in myasthenia gravis

2025

Conference Publication

Effectiveness of Horizontal Switching Between Disease-Modifying Therapies in Multiple Sclerosis

Gomez Figueroa, Enrique, Orozco Puga, Patricia, Corona Vazquez, Cynthia, Moreno Bernardino, Carlos Javier, De la Mora Landin, Graciela, Jimenez-Ruiz, Amado, Garcia Estrada, Christian Alan, Zertuche-Ortuno, Lizeth, Saldivar Davila, Sergio, Rivas, Roberto Rodriguez, Bazan, Anna Lisette, Rivera, Jose Flores, Kalincik, Tomas, Buzzard, Katherine, Khoury, Samia, Duquette, Pierre, Foschi, Matteo, Surcinelli, Andrea, Weinstock-Guttman, Bianca, Gouider, Riadh, Mrabet, Saloua, Lechner-Scott, Jeannette, Butzkueven, Helmut, Alroughani, Raed, Roos, Izanne, Patti, Francesco, Spitaleri, Daniele, McCombe, Pamela, Sanchez Menoyo, Jose Luis ... Ruiz-Sandoval, Jose Luis (2025). Effectiveness of Horizontal Switching Between Disease-Modifying Therapies in Multiple Sclerosis. 41st Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS), Barcelona Spain, Sep 24-26, 2025. LONDON: SAGE PUBLICATIONS LTD.

Effectiveness of Horizontal Switching Between Disease-Modifying Therapies in Multiple Sclerosis

2025

Conference Publication

Bayesian network to generate representative longitudinal data in multiple sclerosis

Qiang, Zhe, Iqbal, Hassam, Sharmin, Sifat, Ozakbas, Serkan, Zakaria, Magd Fouad, Etemadifar, Masoud, Alroughani, Raed, Boz, Cavit, Karabudak, Rana, Shaygannejad, Vahid, Habek, Mario, Terzi, Murat, Yamout, Bassem I., Khoury, Samia, Shalaby, Nevin, Foschi, Matteo, Surcinelli, Andrea, Neri, Stefano, Kermode, Allan, Pedrini, Marzena, Carroll, William, Horakova, Dana, Havrdova, Eva, Soysal, Aysun, Altintas, Ayse, Turkoglu, Recai, Gouider, Riadh, Mrabet, Saloua, Ayuso, Guillermo Izquierdo ... Kalincik, Tomas (2025). Bayesian network to generate representative longitudinal data in multiple sclerosis. 41st Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS), Barcelona Spain, Sep 24-26, 2025. LONDON: SAGE PUBLICATIONS LTD.

Bayesian network to generate representative longitudinal data in multiple sclerosis

2025

Conference Publication

Real-world effectiveness of ocrelizumab in multiple sclerosis: a multi-registry observational cohort study

Roos, Izanne, Sharmin, Sifat, Horakova, Dana, Ozakbas, Serkan, Libertinova, Jana, Boz, Cavit, Alroughani, Raed, Barnett, Michael, van der Walt, Anneke, Butzkueven, Helmut, Rous, Zuzana, Mares, Miroslav, Buzzard, Katherine, Peterka, Marek, Scott, Jeannette Lechner, Foschi, Matteo, Surcinelli, Andrea, Hradilek, Pavel, Prevost, Julie, Brown, William, Eichau, Sara, Blanco, Yolanda, Terzi, Murat, Meca-Lallana, Jose E., Laureys, Guy, Grammond, Pierre, John, Nevin A., Soysal, Aysun, Ampapa, Radek ... Kalincik, Tomas (2025). Real-world effectiveness of ocrelizumab in multiple sclerosis: a multi-registry observational cohort study. 41st Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS), Barcelona Spain, Sep 24-26, 2025. LONDON: SAGE PUBLICATIONS LTD.

Real-world effectiveness of ocrelizumab in multiple sclerosis: a multi-registry observational cohort study

2025

Conference Publication

Disease-Modifying Treatment Cessation or Switch Due to Pregnancy Planning in Women with MS: Is It Safe?

Hradilek, Pavel, Horakova, Dana, Drahota, Jiri, Mazouchova, Aneta, Havrdova, Eva, Vachova, Marta, Ampapa, Radek, Libertinova, Jana, Houskova, Jana, Recmanova, Eva, Dufek, Michal, Mares, Miroslav, Rous, Zuzana, Pavelek, Zbysek, Stetkarova, Ivana, Peterka, Marek, Stourac, Pavel, Mares, Jan, Alroughani, Raed, Ozakbas, Serkan, Karabudak, Rana, Boz, Cavit, Yammout, Bassem, Khoury, Samia, Ayuso, Guillermo Izquierdo, Eichau, Sara, Scott, Jeannette Lechner, McGuigan, Christopher, Prat, Alexandre ... Fistravec, Gregor (2025). Disease-Modifying Treatment Cessation or Switch Due to Pregnancy Planning in Women with MS: Is It Safe?. 41st Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS), Barcelona Spain, Sep 24-26, 2025. LONDON: SAGE PUBLICATIONS LTD.

Disease-Modifying Treatment Cessation or Switch Due to Pregnancy Planning in Women with MS: Is It Safe?

2025

Conference Publication

Real-world Experience with Cladribine Tablets in the MSBase Registry 2025 Update

Spelman, Tim, van der Walt, Anneke, Ozakbas, Serkan, Horakova, Dana, Alroughani, Raed, Kalincik, Tomas, Boz, Cavit, Buzzard, Katherine, Kermode, Allan, Gerlach, O., Foschi, Matteo, Jakob, Gregor Brecl, Grigoriadis, Nikolaos, Prevost, Julie, Duquette, Pierre, Lapointe, Emmanuelle, D'Amico, Emanuele, Ampapa, Radek, Gross-Paju, Katrin, Grammond, Pierre, Cardenas-Robledo, Simon, Houskova, Jana, Khoury, Samia, Maimone, Davide, Sanchez, Jose Luis, McCombe, Pamela, Slee, Mark, Taylor, Bruce, Blanco, Yolanda ... Butzkueven, Helmut (2025). Real-world Experience with Cladribine Tablets in the MSBase Registry 2025 Update. 41st Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS), Barcelona Spain, Sep 24-26, 2025. LONDON: SAGE PUBLICATIONS LTD.

Real-world Experience with Cladribine Tablets in the MSBase Registry 2025 Update

2025

Conference Publication

Single silent lesions matter: a comprehensive assessment of the prognostic impact of clinically silent MRI lesions in RRMS, and an emulated trial of treatment escalation

Daruwalla, Cyrus, Kremler, Courtney, Patti, Francesco, Libertinova, Jana, Ozakbas, Serkan, Peterka, Marek, Vachova, Marta, Boz, Cavit, Scott, Jeannette Lechner, Roos, Izanne, Foschi, Matteo, Surcinelli, Andrea, Neri, Stefano, Khoury, Samia, van der Walt, Anneke, Butzkueven, Helmut, Meca-Lallana, Jose E., Rous, Zuzana, Habek, Mario, Alroughani, Raed, Grammond, Pierre, Blanco, Yolanda, Laureys, Guy, Buzzard, Katherine, Skibina, Olga, Gray, Orla, Mccombe, Pamela, Izquierdo Ayuso, Guillermo, Eichau, Sara ... Brown, William (2025). Single silent lesions matter: a comprehensive assessment of the prognostic impact of clinically silent MRI lesions in RRMS, and an emulated trial of treatment escalation. 41st Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS), Barcelona Spain, Sep 24-26, 2025. LONDON: SAGE PUBLICATIONS LTD.

Single silent lesions matter: a comprehensive assessment of the prognostic impact of clinically silent MRI lesions in RRMS, and an emulated trial of treatment escalation

2025

Journal Article

Segmentation of the human tongue musculature using MRI: Field guide and validation in motor neuron disease

Shaw, Thomas B., Ribeiro, Fernanda L., Zhu, Xiangyun, Aiken, Patrick, Bollmann, Saskia, Bollmann, Steffen, Chang, Jeryn, Chidley, Kali, Dempsey-Jones, Harriet, Eftekhari, Zeinab, Gillespie, Jennifer, Henderson, Robert D., Kiernan, Matthew C., Ktena, Ira, McCombe, Pamela A., Ngo, Shyuan T., Taubert, Shana T., Whelan, Brooke-Mai, Ye, Xincheng, Steyn, Frederik J., Tu, Sicong and Barth, Markus (2025). Segmentation of the human tongue musculature using MRI: Field guide and validation in motor neuron disease. Computers in Biology and Medicine, 196 (Part B) 110824, 1-13. doi: 10.1016/j.compbiomed.2025.110824

Segmentation of the human tongue musculature using MRI: Field guide and validation in motor neuron disease

2025

Conference Publication

Stronger Together: Bayesian Evidence from Four Countries Reinforces Early High-Efficacy Treatment in Multiple Sclerosis

Stastna, Dominika, Horakova, Dana, Drahota, Jiri, Mazouchova, Aneta, Kovarova, Ivana, Barnett, Michael, Kalincik, Tomas, Buzzard, Katherine, van der Walt, Anneke, Macdonell, Richard, Scott, Jeannette Lechner, John, Nevin A., Mccombe, Pamela, Hodgkinson, Suzanne, Taylor, Bruce, Slee, Mark, Garber, Justin, Havrdova, Eva, Vachova, Marta, Ampapa, Radek, Libertinova, Jana, Houskova, Jana, Recmanova, Eva, Dufek, Michal, Mares, Miroslav, Hradilek, Pavel, Rous, Zuzana, Pavelek, Zbysek, Stetkarova, Ivana ... Fistravec, Gregor (2025). Stronger Together: Bayesian Evidence from Four Countries Reinforces Early High-Efficacy Treatment in Multiple Sclerosis. 41st Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS), Barcelona Spain, Sep 24-26, 2025. LONDON: SAGE PUBLICATIONS LTD.

Stronger Together: Bayesian Evidence from Four Countries Reinforces Early High-Efficacy Treatment in Multiple Sclerosis

2025

Conference Publication

Safety-Driven Ocrelizumab Discontinuation vs Continuation: Comparative Insights from MSBase

D'Amico, Emanuele, Zanghi, Aurora, Spelman, Tim, Kermode, Allan G., Pedrini, Marzena, Carroll, William, Lechner-Scott, Jeannette, van der Walt, Anneke, Butzkueven, Helmut, John, Nevin A., Kalincik, Tomas, Roos, Izanne, Boz, Cavit, Ozakbas, Serkan, Barnett, Michael, Hodgkinson, Suzanne, Habek, Mario, Buzzard, Katherine, Skibina, Olga, Grammond, Pierre, Alroughani, Raed, Laureys, Guy, Horakova, Dana, Havrdova, Eva, Izquierdo, Guillermo H., Eichau, Sara, Mccombe, Pamela, Massey, Jennifer, Aragon de Vecino, Maria Cecilia ... Gerlach, Oliver (2025). Safety-Driven Ocrelizumab Discontinuation vs Continuation: Comparative Insights from MSBase. 41st Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS), Barcelona Spain, Sep 24-26, 2025. LONDON: SAGE PUBLICATIONS LTD.

Safety-Driven Ocrelizumab Discontinuation vs Continuation: Comparative Insights from MSBase

2025

Conference Publication

Real-World Management of Multiple Sclerosis after Cancer Chemotherapy

Nesbitt, Cassie, Sanfilippo, Paul, Zhu, Chao, Ozakbas, Serkan, Prat, Alexandre, Girard, Marc, Duquette, Pierre, Kalincik, Tomas, Roos, Izanne, Buzzard, Katherine, Skibina, Olga, Foschi, Matteo, Surcinelli, Andrea, Boz, Cavit, Scott, Jeannette Lechner, Libertinova, Jana, Patti, Francesco, Kermode, Allan, Carroll, William, Barnett, Michael, Hodgkinson, Suzanne, Grand'Maison, Francois, Horakova, Dana, Havrdova, Eva, Blanco, Yolanda, Hradilek, Pavel, Vachova, Marta, Habek, Mario, Maimone, Davide ... Jokubaitis, Vilija (2025). Real-World Management of Multiple Sclerosis after Cancer Chemotherapy. 41st Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS), Barcelona Spain, Sep 24-26, 2025. LONDON: SAGE PUBLICATIONS LTD.

Real-World Management of Multiple Sclerosis after Cancer Chemotherapy

2025

Conference Publication

Treatment strategies after cell-trafficking agents in MS patients older than 50 years

Muller, Jannis, Benkert, Pascal, Horakova, Dana, Havrdova, Eva, Buzzard, Katherine, Skibina, Olga, Ozakbas, Serkan, Lechner Scott, Jeannette, Izquierdo Ayuso, Guillermo, Eichau, Sara, Weinstock-Guttman, Bianca, Hodgkinson, Suzanne, Grammond, Pierre, Barnett, Michael, Prat, Alexandre, Girard, Marc, Duquette, Pierre, van der Walt, Anneke, Butzkueven, Helmut, John, Nevin A., Meca-Lallana, Jose E., Prevost, Julie, Gerlach, O., Boz, Cavit, McCombe, Pamela, Lugaresi, Alessandra, Tomassini, Valentina, Kermode, Allan, Pedrini, Marzena ... Roos, Izanne (2025). Treatment strategies after cell-trafficking agents in MS patients older than 50 years. 41st Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS), Barcelona Spain, Sep 24-26, 2025. LONDON: SAGE PUBLICATIONS LTD.

Treatment strategies after cell-trafficking agents in MS patients older than 50 years

2025

Conference Publication

Late-Onset Multiple Sclerosis: Do High-Efficacy Treatments Deliver Better Outcomes?

Foong, Yi Chao, Merlo, Daniel, Gresle, Melissa, Buzzard, Katherine, Horakova, Dana, Havrdova, Eva, Kalincik, Tomas, Roos, Izanne, Hodgkinson, Suzanne, Scott, Jeannette Lechner, Lugaresi, Alessandra, Weinstock-Guttman, Bianca, Ozakbas, Serkan, Surcinelli, Andrea, Foschi, Matteo, Boz, Cavit, Khoury, Samia, Yamout, Bassem, Laureys, Guy, Blanco, Yolanda, Skibina, Olga, Kuhle, Jens, John, Nevin A., Alroughani, Raed, Prevost, Julie, Van Pesch, Vincent, Tomassini, Valentina, Prat, Alexandre, Terzi, Murat ... van der Walt, Anneke (2025). Late-Onset Multiple Sclerosis: Do High-Efficacy Treatments Deliver Better Outcomes?. 41st Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS), Barcelona Spain, Sep 24-26, 2025. LONDON: SAGE PUBLICATIONS LTD.

Late-Onset Multiple Sclerosis: Do High-Efficacy Treatments Deliver Better Outcomes?

2025

Conference Publication

Machine Learning-Generated Longitudinal Synthetic International Data in Multiple Sclerosis

Iqbal, Hassam, Qiang, Zhe, Sharmin, Sifat, Ball, Gareth, Brankovic, Aida, Horakova, Dana, Havrdova, Eva, Ozakbas, Serkan, Shaygannejad, Vahid, Karabudak, Rana, Patti, Francesco, Zamzam, Dina, Alroughani, Raed, Etemadifar, Masoud, Boz, Cavit, Ayuso, Guillermo Izquierdo, Eichau, Sara, Terzi, Murat, Prat, Alexandre, Girard, Marc, Duquette, Pierre, Amato, Maria Pia, Grand'Maison, Francois, Kermode, Allan, Pedrini, Marzena, Carroll, William, Yamout, Bassem I., Khoury, Samia, Shalaby, Nevin ... Kalincik, Tomas (2025). Machine Learning-Generated Longitudinal Synthetic International Data in Multiple Sclerosis. 41st Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS), Barcelona Spain, Sep 24-26, 2025. LONDON: SAGE PUBLICATIONS LTD.

Machine Learning-Generated Longitudinal Synthetic International Data in Multiple Sclerosis

2025

Journal Article

Haematopoietic stem cell transplant versus immune-reconstitution therapy in relapsing multiple sclerosis

Kalincik, Tomas, Sharmin, Sifat, Roos, Izanne, Freedman, Mark S, Atkins, Harold, Massey, Jennifer, Sutton, Ian, Withers, Barbara, Burman, Joachim, Torkildsen, Øivind, Bø, Lars, Lehmann, Anne Kristine, Havrdova, Eva Kubala, Krasulova, Eva, Trneny, Marek, Kozak, Tomas, Macdonell, Richard, Brown, J William L, Coles, Alasdair, van der Walt, Anneke, Butzkueven, Helmut, Van Wijmeersch, Bart, Lechner-Scott, Jeannette, Barnett, Michael, Laureys, Guy, Willekens, Barbara, Buzzard, Katherine, Skibina, Olga, Di Gregorio, Maria ... Snowden, John A (2025). Haematopoietic stem cell transplant versus immune-reconstitution therapy in relapsing multiple sclerosis. Brain, 149 (3) awaf286, 951-962. doi: 10.1093/brain/awaf286

Haematopoietic stem cell transplant versus immune-reconstitution therapy in relapsing multiple sclerosis

2025

Journal Article

Applying high-density surface EMG to the study of neuromuscular disorders: a systematic review

Shandiz, Ehsan, Gaskell, Asbjorn, Ingram, Matthew, Trajano, Gabriel, Fernandes, Gabriel L., Henkin, Joao, McCombe, Pamela and Henderson, Robert (2025). Applying high-density surface EMG to the study of neuromuscular disorders: a systematic review. Clinical Neurophysiology, 179 2110983, 2110983. doi: 10.1016/j.clinph.2025.2110983

Applying high-density surface EMG to the study of neuromuscular disorders: a systematic review

2025

Journal Article

Personalized federated learning for predicting disability progression in multiple sclerosis using real-world routine clinical data

Pirmani, Ashkan, De Brouwer, Edward, Arany, Ádám, Oldenhof, Martijn, Passemiers, Antoine, Faes, Axel, Kalincik, Tomas, Ozakbas, Serkan, Gouider, Riadh, Willekens, Barbara, Horakova, Dana, Havrdova, Eva Kubala, Patti, Francesco, Prat, Alexandre, Lugaresi, Alessandra, Tomassini, Valentina, Grammond, Pierre, Cartechini, Elisabetta, Roos, Izanne, Boz, Cavit, Alroughani, Raed, Amato, Maria Pia, Buzzard, Katherine, Lechner-Scott, Jeannette, Guimarães, Joana, Solaro, Claudio, Gerlach, Oliver, Soysal, Aysun, Kuhle, Jens ... Moreau, Yves (2025). Personalized federated learning for predicting disability progression in multiple sclerosis using real-world routine clinical data. npj Digital Medicine, 8 (1) 478. doi: 10.1038/s41746-025-01788-8

Personalized federated learning for predicting disability progression in multiple sclerosis using real-world routine clinical data

2025

Journal Article

Four years on: Pregnancy and birth outcomes reported in the MSBase pregnancy, neonatal outcomes, and Women’s Health Registry (2020–2024)

Jokubaitis, Vilija G, Alroughani, Raed, Altintas, Ayse, Eichau, Sara, Hughes, Stella, Willekens, Barbara, Horakova, Dana, Havrdova, Eva Kubala, Ozakbas, Serkan, Boz, Cavit, Habek, Mario, Kalincik, Tomas, Roos, Izanne, Etemadifar, Masoud, Peterka, Marek, Lechner-Scott, Jeannette, Meca-Lallana, Jose E, Rous, Zuzana, Houskova, Jana, Prat, Alexandre, Girard, Marc, Ampapa, Radek, Buzzard, Katherine, Skibina, Olga, John, Nevin A, Kermode, Allan G, Fabis-Pedrini, Marzena J, Foschi, Matteo, Surcinelli, Andrea ... MSBase Study Investigators (2025). Four years on: Pregnancy and birth outcomes reported in the MSBase pregnancy, neonatal outcomes, and Women’s Health Registry (2020–2024). Multiple Sclerosis Journal, 31 (9), 1088-1101. doi: 10.1177/13524585251349125

Four years on: Pregnancy and birth outcomes reported in the MSBase pregnancy, neonatal outcomes, and Women’s Health Registry (2020–2024)

2025

Journal Article

Standardized definition of Progression Independent of Relapse Activity (PIRA) in relapsing-remitting multiple sclerosis

Müller, Jannis, Sharmin, Sifat, Lorscheider, Johannes, Ozakbas, Serkan, Karabudak, Rana, Horakova, Dana, Weinstock-Guttman, Bianca, Shaygannejad, Vahid, Etemadifar, Masoud, Alroughani, Raed, Patti, Francesco, Eichau, Sara, Prat, Alexandre, Lugaresi, Alessandra, Tomassini, Valentina, Kermode, Allan G., Amato, Maria Pia, Turkoglu, Recai, Altintas, Ayse, Buzzard, Katherine, Soysal, Aysun, Van Der Walt, Anneke, Butzkueven, Helmut, Blanco, Yolanda, Gerlach, Oliver, Khoury, Samia J., Barnett, Michael, John, Nevin, Lechner-Scott, Jeannette ... Granziera, Cristina (2025). Standardized definition of Progression Independent of Relapse Activity (PIRA) in relapsing-remitting multiple sclerosis. JAMA Neurology, 82 (6), 614-625. doi: 10.1001/jamaneurol.2025.0495

Standardized definition of Progression Independent of Relapse Activity (PIRA) in relapsing-remitting multiple sclerosis

2025

Journal Article

Explainable time-to-progression predictions in multiple sclerosis

D’hondt, Robbe, Dedja, Klest, Aerts, Sofie, Van Wijmeersch, Bart, Kalincik, Tomas, Reddel, Stephen, Havrdova, Eva Kubala, Lugaresi, Alessandra, Weinstock-Guttman, Bianca, Mrabet, Saloua, Lalive, Patrice, Kermode, Allan G., Ozakbas, Serkan, Patti, Francesco, Prat, Alexandre, Tomassini, Valentina, Roos, Izanne, Alroughani, Raed, Gerlach, Oliver, Khoury, Samia J., van Pesch, Vincent, Sa, Maria Jose, Prevost, Julie, Spitaleri, Daniele, McCombe, Pamela, Solaro, Claudio, van der Walt, Anneke, Butzkueven, Helmut, Laureys, Guy ... Vens, Celine (2025). Explainable time-to-progression predictions in multiple sclerosis. Computer Methods and Programs in Biomedicine, 263 108624, 1-23. doi: 10.1016/j.cmpb.2025.108624

Explainable time-to-progression predictions in multiple sclerosis